| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e296c344a6aa73b0e906672390725b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3d4ad89a2acb92b6c8ee94e4ec0326e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2030f3239ae84308f414f74959944f2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8308c402a5e9c255ebd0e3c314f23be5 |
| publicationDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10391109-B2 |
| titleOfInvention |
Use of zoledronic acid to prepare drug treating fatty liver disease |
| abstract |
A method for treating fatty liver disease in a patient in need thereof, including a step of administering an effective amount of zoledronic acid. The fatty liver disease includes fatty liver disease caused by foodborne and hereditary factors, in particular non-alcoholic fatty liver. A dosage form of the zoledronic acid is an injection, a solution, a tablet, or a capsule. |
| priorityDate |
2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |